Samik Pharm KRX:014950KOSDAQ
삼익제약 · Korean news coverage and regulatory filings, organized.
Articles, 24h6
Articles, 7 days9
DART filings, 7 days0
Articles tracked9since Sep 11
In Q2 2026, Samik Pharm reported revenue of ₩15.7bn, up 5.2% year on year, and an operating loss of ₩228m. Samik Pharm (삼익제약) appeared in 9 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 6 articles. The most common catalyst was tech & capacity (2). It was most often mentioned alongside Lightron Fiber-optic Devices and Auk.
Samik Pharm quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩15.7bn | +5.2% | −₩228m | −₩77m |
| Q1 2026 | ₩15.5bn | +10.4% | ₩929m | ₩1.2bn |
| Q4 2025 derived | ₩15.2bn | +8.1% | ₩49m | −₩3.6bn |
| Q3 2025 | ₩15.8bn | +11.2% | ₩1.1bn | ₩937m |
| Q2 2025 | ₩14.9bn | +4.9% | ₩1.1bn | ₩716m |
| Q1 2025 | ₩14.0bn | – | ₩1.0bn | ₩1.2bn |
| Q4 2024 derived | ₩14.1bn | – | ₩501m | ₩426m |
| Q3 2024 | ₩14.2bn | – | ₩1.3bn | ₩1.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Samik Pharm top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest Samik Pharm news Korean headlines
-
KRX 애프터마켓 첫 시행… 광전자·빛과전자·삼익제약 거래량 급증
1 more on this story · 1 outlets
- KRX 애프터마켓 첫날…광전자·빛과전자 등 거래량 상위권아주경제 · Sep 14 17:02
